Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 

       2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Oxethazaine taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
Oxethazaine Manufacturers in India Suppliers Oxethazaine Exporters Distributors Oxethazaine api active pharmaceuticals ingredients Oxethazaine manufacturers Side Effects bulk drugs raw material Oxethazaine companies Side Effects Importers Oxethazaine Oxethazaine Exporters Oxethazaine exporters FDA Oxethazaine DMF Symptoms Generic Taj Pharmaceuticals Ltd. active pharmaceutical ingredients suppliers pharmaceutical Oxethazaine manufacturing pharmaceutical drugs pharmaceutical intermediates Oxethazaine pharmaceutical chemicals pharmaceutical raw materials Oxethazaine active pharmaceutical ingredients Oxethazaine committee active pharmaceutical ingredients manufacturer Oxethazaine Active Pharmaceutical Ingredients manufacturer Oxethazaine exporter drug ingredients pharmaceuticals Pharmaceuticals API Manufacturer Oxethazaine, Oxethazaine manufacturer India, Oxethazaine product, Oxethazaine products, Api preparation, Certificate of Analysis API manufacturer product, Oxethazaine anti ulcer product, Certificate of Origin COA Oxethazaine COS Oxethazaine, pharmaceutical generic, pharmaceutical drug, medical, Oxethazaine pharma healthcare, pharma patents, contract MSDS manufacturing Trader Oxethazaine pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Oxethazaine expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Oxethazaine DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Oxethazaine ingredients, api, HIV Oxethazaine, tablets, capsules, syrup & protein Oxethazaine powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Oxethazaine gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Oxethazaine WHO, UKMHRA Approval
   API >>>
   Pharmaceuticals API List
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us







HOME >> API >> API List 3 >> Oxethazaine >> Interaction

Oxethazaine CAS Registry Number 126-27-2

Oxethazaine CAS Registry Number 126-27-2

The rate and/or extent of absorption of many drugs may be increased or decreased when they are used concurrently with aluminum-magnesium hydroxide- containing antacids. Therefore, as a general rule, medication should not be taken within 1 to 2 hours of an antacid, if possible.

An incomplete list of substances for which the above statement has been shown to apply includes; tetracycline, iron salts, chlorpromazine, levodopa, isoniazid, digoxin, H2-antagonists, indomethacin, nitrofurantoin, and dicumarol.

An increase in the plasma level of quinidine and possible toxicity may result if alkalization of the urine occurs during antacid therapy.

Information Associated with Product:
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo


Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.